Why we may need to rethink future SARS-CoV-2 vaccination strategies
Main Author: | Peter Klimek |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | The Lancet Regional Health. Europe |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666776221001915 |
Similar Items
-
Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be
by: Giuseppina Mariano, et al.
Published: (2020-12-01) -
While We Wait for a Vaccine Against SARS-CoV-2, Why Not Think About Available Drugs?
by: Francisco J. Barrantes
Published: (2020-07-01) -
SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01) -
Why we need to rethink the diseases of affluence.
by: Thomas E Novotny
Published: (2005-05-01) -
The Origin of Sars-CoV-2: Why It Matters
by: Paolo Vineis, et al.
Published: (2021-09-01)